The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the heart transplant market’s growth in recent years?
The prevalence of cardiovascular diseases is expected to propel the growth of the heart transplant market going forward. Cardiovascular diseases are a range of conditions that affect the heart and blood arteries. A heart transplant is a last-resort treatment for people with end-stage heart failure who have not responded to other treatments. It improves quality of life and extends life expectancy. For instance, in September 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million individuals are currently affected by heart and circulatory diseases, comprising 4 million men and 3.6 million women. By 2030, this number could increase by 1 million, and by 2040, it may rise to 2 million more than the current figures. Therefore, the prevalence of cardiovascular diseases will drive the heart transplant market.
Heart Transplant Market Driver: Growth Of The Heart Transplant Market Fueled By Growing Awareness About Organ Donation And Transplantation
The growing awareness about organ donation and transplantation is expected to propel the growth of the heart transplant market going forward. Awareness about organ donation and transplantation refers to the level of knowledge, understanding, and consciousness among individuals and communities regarding the processes, significance, and impact of organ donation and transplantation in healthcare. Increasing awareness about organ donation and transplantation significantly influences the field of heart transplants by expanding the donor pool, shortening waiting times for recipients, and enhancing patient outcomes. For instance, in January 2023, according to the United Network for Organ Sharing, a US-based non-profit scientific and educational organization, a new yearly record of 42,887 organ transplants were carried out in the US in 2022, up 3.7% from 2021. Furthermore, due to the established awareness of liver transplants with 9,528 procedures, heart transplants with 4,111 surgeries, and lung transplants with 2,692 operations performed. Therefore, the growing awareness about organ donation and transplantation will drive the heart transplant market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp
How does the future projection of the heart transplant market size compare to its historical growth?
The heart transplant market size has grown rapidly in recent years. It will grow from $11.49 billion in 2024 to $12.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to medical advancements, increased awareness and education, advancements in organ preservation, healthcare infrastructure.
The heart transplant market size is expected to see strong growth in the next few years. It will grow to $18.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to government support and funding, globalization of transplant programs, increasing transplant center capacity, integration of telemedicine and remote monitoring. Major trends in the forecast period include technological advancements, artificial heart and assist devices, artificial intelligence (AI) in donor organ selection.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp
Which key players are shaping the future of the heart transplant market?
Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.
What trends will propel the growth and evolution of the heart transplant market?
Major companies operating in the heart transplant market are increasingly focused on developing innovative solutions, such as heart preservation technology, to improve patient outcomes and transplant success rates. It significantly extends the preservation time of the heart outside the body compared to traditional ice storage, allowing for improved outcomes and reduced complications post-transplantation. For instance, in May 2023, Xvivo Perfusion AB, a Sweden-based medical technology company, got approval from the U.S. Food and Drug Administration (FDA) for Investigational Device Exemption (IDE) application for its heart preservation technology, allowing the company to initiate the “PRESERVE Clinical Trial.” This trial is a prospective, multicenter, single-arm, open-label study focused on evaluating hearts transplanted after non-ischemic heart preservation from extended donors, specifically including Donation after Circulatory Death (DCD) hearts. The main unique feature of XVIVO’s heart preservation technology is its non-ischemic hypothermic perfusion system, which utilizes cold, oxygenated perfusion to preserve donor hearts during transport.
Which regions are expected to become dominant players in the heart transplant market?
North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report
What are the emerging key segments in the heart transplant market, and how are they evolving?
The heart transplant market covered in this report is segmented –
1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types
2) By Transplant: Autograft, Allograft, Other Transplants
3) By End-User: Hospitals, Cardiac Institutes, Other End-Users
Subsegments:
1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart
2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)
3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)
4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967
How is the heart transplant market defined, and what are its core characteristics?
A heart transplant is a medical operation that involves removing and replacing a damaged or diseased heart with a healthy donor heart. It is a complex and life-saving medical intervention for individuals with end-stage heart failure or certain severe heart diseases.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
